Biotech IB... top groups/offices?
Trending Content - Investment Banking Forum
Career Resources
WSO Free Modeling Series - Now Open Through
October 31, 2026
9 Free Financial Modeling Lessons
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
+Bonus: Get 27 financial modeling templates in swipe file
+Bonus: Get 27 financial modeling templates in swipe file
High Finance Applications
Guaranteed
Get at least one offer GUARANTEED
- 1:1 support
- 92% success rate
- 2,000+ mentor network
- Unlimited Live bootcamps
- AI for resume + LinkedIn
- Networking automation tools
- HireVue simulation tool
- Full course library
- Private Slack community
- 20hrs of mocks
- + much more...
JPM Hong Kong is pretty focused on healthcare. Apart from that, a number of middle market firms in that range in sell-side. From what I remember faintly, Cain Bros SF and Cowen and Company are also leading in healthcare. Haven't heard of a strong rep from Wells Fargo SF.
Thanks! But do they also cover Biotech in HK?
I know Cain's pretty strong in HC, but they do not cover Biotech (yet), only pharma and services...
Dunno about biotech specifically, but if you're narrowing down to specific Biotech coverage, I doubt you'd find many banks doing so. Even if they would, they wouldn't hire a guy rightaway out of undergrad SPECIFICALLY for the biotech group (you'll have to go through the generalist process and yada yada), or you could hedge your bets and luck out too. Best bet is to go for pharma focused groups.
Note, I'm advising coming from the same problems as you. I once focused on just biotech groups and did not get selected in any banks for internships. Ended up going into an engineering intern that summer. Which sucked. Don't want to get into that quagmire.
I've seen biotech in Boston offices for a few banks; Piper, Baird off the top of my head. There are a lot of boutiques out there too (Leerink, JSB, Backbay Life Sciences, etc). If you're really that passionate about biotech, theres a lot of consulting for Biotech out there as well. I dont think there are many big banks with groups specifically covering biotech companies, mostly its just HC groups that cover all verticals.
Agree with this. Boston is great for healthcare opportunities, while SF banks are just too hard to get into, considering everyone's behind tech and HC in Cal. Ideally though, you should be looking at where your school is to maximize chances.
For Piper HC in Mpls is broken up into 3 verticals: medtech, HCIT, biopharm/biotech.
Thought their main biopharma office was NYC though...whats in MPLS?
Pretty confident Baird does not have a IBD office in Boston. Piper's office is like 10 ppl only doing Tech.
They have 2 IBD positions in Boston listed on their website right now.
They most definitely have a life sciences office in Boston.
Would add Cowen and Leerink to the boutique list.
Cantor is actually making a huge push up after they hired Sage Kelly. They just recently started building out the research arm by drawing over some big name analysts and brought over Barclays head of US equities to lead their global equities business unit.
I would def shoot for going there because no doubt orgies and, for the more senior crowd, wifeswaps, will be included in your comp package.
I didn't know about this. When did Cantor become a fuckshow? Thought they became real solemn after 9/11.
In SF, Wells Fargo is strong in biotech -- but I know someone who worked there and was basically a slave.
I've heard of the shit culture at WFC in general (not encouraging of exits, too slow and hierarchial compared to other firms), but not heard of it being a strong biotech shop. Usual names are MS, Laz and JPM, though I may also be wrong/underexposed.
leerink jeffries Cowen are all really good. cantor is doing really well getting exclusive book runner on a lot of deals, but the word on the street is that the VC's are getting upset with Cantor for selling bought deals. A lot of their clients wont be banking with them again.
http://www.roth.com
Roth hc team just left for op. Co
FYI, this is a SF perspective. Can't believe no one mentioned CV... CV has been killing it in biotech the past few years; I would say CV is the current leader (coming from someone heading into a life sciences HC team that's not CV). JPM LAZ and GS (WRA) are strong too.
Also, just to answer your question on whether GS WRA covers biotech--yes they do. Have a friend who worked there this summer.
Aut dolorem id illum quidem ratione impedit. Iusto illum esse animi sunt voluptas nobis.
Et enim cum repellendus porro. Et nostrum sit inventore autem consequuntur. Omnis atque similique repellendus quis impedit magni ut. Non totam quod alias at ut dignissimos quia. Reprehenderit illum ab sed minus. Voluptates sunt natus quia et accusamus ex hic. Numquam dignissimos dolorem est nam a quia.
Quo corrupti nihil incidunt consectetur omnis quia consequatur pariatur. Numquam quae eos molestias nulla dignissimos quasi numquam.
Tempora ab deserunt in et delectus. Nemo et accusantium et iste quasi. Dolorem soluta eum occaecati officiis sint rerum. Suscipit perferendis eaque ea praesentium delectus sit quos sapiente.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...
Est explicabo molestiae minus id laudantium. Exercitationem quaerat autem molestiae. Omnis numquam ea deserunt aut est quia aut. Pariatur excepturi quas ut. Ducimus sunt non consequatur culpa. Alias amet consequatur et minima repellat sint blanditiis. Accusamus et consequuntur repudiandae odio reiciendis.
Omnis in maiores molestias consectetur voluptas voluptatem. Omnis dolorem earum sint aut et. Dignissimos sint aut exercitationem laudantium earum possimus aliquid sit. Ut ut non in quia optio voluptas sit. Aspernatur nesciunt quia non ut reiciendis minus voluptas.
Vel vel ea nulla non error eveniet mollitia. Ut suscipit autem voluptas omnis eos recusandae explicabo. Voluptas sint laborum qui cumque. Ipsum odit minima autem reiciendis omnis. Nam eaque voluptas aut doloremque explicabo dolores soluta. Perspiciatis tempora maxime possimus dolores. Quia et nulla voluptatem velit autem tempora.